Mycobacterium tuberculosis (M. tuberculosis) in latently infected individuals survives and thwarts the attempts of eradication by the immune system. During latency, Acr1 is predominantly expressed by the bacterium. However, whether M. tuberculosis exploits its Acr1 in impairing the host immunity remains widely unexplored. Hence, currently we have investigated the role of Acr1 in influencing the differentiation and function of dendritic cells (DCs), which play a cardinal role in innate and adaptive immunity. Therefore, for the first time, we have revealed a novel mechanism of mycobacterial Acr1 in inhibiting the maturation and differentiation of DCs by inducing tolerogenic phenotype by modulating the expression of PD-L1; Tim-3; indoleamine 2, 3-dioxygenase (IDO); and interleukin 10. Furthermore, Acr1 interferes in the differentiation of DCs by targeting STAT-6 and STAT-3 pathways. Continuous activation of STAT-3 inhibited the translocation of NF-κB in Acr1-treated DCs. Furthermore, Acr1 also augmented the induction of regulatory T cells. These DCs displayed decline in their antigen uptake capacity and reduced ability to help T cells. Interestingly, M. tuberculosis exhibited better survival in Acr1-treated DCs. Thus, this study provides a crucial insight into a strategy adopted by M. tuberculosis to survive in the host by impairing the function of DCs.
One-third of the world's population is infected with Mycobacterium tuberculosis (M. tuberculosis), the etiological agent of tuberculosis [1] . During latency, it tames and tunes the host immunity to successfully survive [2] [3] [4] . Consequently, it is of utmost importance to understand the intricate host-pathogen interaction and the strategies M. tuberculosis adopts to circumvent defense mechanism of the host. M. tuberculosis expresses numerous factors in the infected macrophages and DCs to systematically deteriorate the function of both macrophages and DCs [5] [6] [7] [8] [9] . Many studies signify the role of M. tuberculosis antigens such as CFP-10, ESAT-6, etc, expressed during active tuberculosis in modulating the function of macrophages and DCs [10] [11] [12] . However, whether M. tuberculosis employs its latency-associated antigens in manipulating the function of macrophages and DCs remains broadly undefined. M. tuberculosis small heat shock protein X (sHSPX), also known as Acr1 or HSP16.3, is predominantly expressed in the latent phase of infection and is increased in response to stress [13] [14] [15] [16] . Whether Acr1 can affect the DC's differentiation, maturation, cytokine secretion, and ability to stimulate T cells needs to be investigated.
Tuberculosis granuloma guards the host from dissemination of M. tuberculosis and also facilitates the survival of bacterium [17] . DCs present in granuloma exhibit downregulation of costimulatory and increased coinhibitory molecules expression. Such DCs may induce tolerance and therefore promote M. tuberculosis survival. Further, an augmented pool of regulatory T cells (Tregs) has been noted in latency, which suppresses type 17 T-helper (Th17) cells [18] [19] [20] [21] . Th17 cells are quite crucial in providing immunity against M. tuberculosis [22] . Hence, enhancement in Treg populations and decrease in Th17 cells will lead to impaired response against M. tuberculosis.
DCs not only activate naive T cells to initiate effector response but are also capable of generating tolerance [23] . It has been demonstrated that M. tuberculosis can hide in bone marrow mesenchymal stem cells [24] , thus possibly affecting the differentiation of monocytes and DCs. Furthermore, DCs can disseminate mycobacterial infection [25, 26] . For these reasons, the role of Acr1 was investigated on DCs. We observed that Acr1 interferes with the maturation and differentiation of bone marrow cells (BMCs) to DCs, thereby impeding their function to activate immune response. Therefore, this finding provides a novel perceptiveness regarding the importance of Acr1 as a potent drug target and vaccine candidate.
MATERIALS AND METHODS

Dendritic Cell Culture
BMCs were collected from femurs and tibiae of C3H/HeN mice. Cells (2 × 10 6 /well) were cultured with granulocyte macrophage colony-stimulating factor (GM-CSF; 1 ng/mL), interleukin 4 (IL-4; 2 ng/mL) and in the presence/absence of either Acr1, CFP-10, ESAT-6, and BSA (non-M. tuberculosis protein). DCs generated in the presence of Acr1 are depicted in text as Acr1DCs. On day 3, cultures were replenished with media (50%) supplemented with GM-CSF, IL-4 and respective proteins. On day 6, cells were harvested and interleukin 12 (IL-12) was measured in the supernatants.
Allogeneic T-Cell Proliferation
Acr1DCs (C3H/HeN) irradiated at 3000 rad were cocultured with CD4 T cells (BALB/c) at a ratio of 1:20. After 72 hours, 3 H-thymidine (0.5 µCi/well) was added into the cultures. The plates were harvested after 16 hours and radioactivity incorporated was measured as counts per minute (cpm) through scintillation counting. In parallel, cultures were set for 48 hours for cytokine estimation (interleukin 5 and interferon gamma [IFN-γ]).
Antigen Uptake by Acr1DCs
Acr1DCs were pulsed with horseradish peroxidase (HRP; 100 µg/mL) at 37°C and chased for 30 minutes. Antigen uptake was arrested by adding chilled phosphate-buffered saline (PBS) at 4°C
. Cells were washed extensively with ice-cold PBS-fetal bovine serum 1%. HRP uptake was measured by adding OPD (Ophenylenediamine dihydrochloride) at a concentration of 10 mg/ 10 mL + 10 µL H 2 O 2 to soluble fraction of lysed cells. Reaction was stopped with 7% H 2 SO 4 . Plate was read at 492 nm.
For flow cytometry experiments, cells were pulsed with dextran-fluorescein isothiocyanate (FITC) (100 µg/mL) at 37°C and chased for 30 minutes. Cells kept at 4°C were used as control. Cells were acquired for the uptake of dextran-FITC using FACSCalibur and analyzed by FACSDiva software. For confocal analysis, Acr1DCs were placed on poly-L-lysinecoated coverslips and imaged using the Nikon A1 Confocal Laser Microscope system. Analysis was done using Nikon NISElements C image analysis software.
RESULTS
Acr1 Antigen of M. tuberculosis Suppresses the Differentiation of DCs
Latent form of M. tuberculosis infection is one of the major burden in developing countries [27] . M. tuberculosis predominantly expresses Acr1 during latency [13, 15] . DCs are potent antigen-presenting cells (APCs) capable of activating naive T cells. However, upon infection, M. tuberculosis can infect DCs and successfully hamper their function [5] . Hence, we were curious to know the impact of Acr1 on the maturation and differentiation of DCs. We cultured BMCs with various concentrations of Acr1 (0-9 µg/mL), in the presence of DC differentiating cytokines GM-CSF and IL-4. We used endotoxin-free recombinant Acr1 in all the experiments (Supplementary Figure 1 , A-C). We observed dose-dependent decline in the percentage of CD11c
+ DCs with the increase in the concentration of Acr1 ( Figure 1A ). No change was noticed in the viability of Acr1DCs ( Figure 1B ). The ability of DCs to express major histocompatibility complex (MHC), costimulatory or coinhibitory molecules, makes them potent cells to modulate T-cell immune response. Intriguingly, Acr1 induced significant downregulation of MHC-II (P < .05) and costimulatory molecules, namely, CD80 (P < .05), CD86 (P < .005), and CD40 (P < .005) ( Figure 1C ). In contrast, significant (P < .05) upregulation was noticed in the coinhibitory molecules PD-L1 ( Figure 1C ). The ratio of costimulatory (CD86) to coinhibitory (PD-L1) molecules was also substantially reduced (P < .005; Figure 1D ). For methodology see Supplementary Materials and Methods.
Tim-3 is considered to be a prominent coinhibitory molecule; hence, we also checked the influence of Acr1 in influencing its expression. CFP-10 and ESAT-6 of M. tuberculosis and BSA (non mycobacterial protein) were used as controls to establish the specificity of Acr1. Interestingly, Acr1DCs showed significantly (P < .05) higher expression of Tim-3 than did CFP-10, ESAT-6, and BSA ( Figure 1E and 1F). It was also noted that CFP-10, BSA, and ESAT-6 did not substantially alter the expression of CD80, CD86, MHC-II, or PD-L1 on DCs (Supplementary Figure 2A and 2B). Thus, it is quite evident from these results that the observed effect on Acr1DCs is explicitly due to Acr1 of M. tuberculosis.
Cytokines such as IL-12 secreted by DCs confer an instrumental role in skewing CD4 T cells toward Th1 phenotype [28] . , and iMFI (E and F ) are of 2-3 independent experiments. G, Supernatants were collected from the DCs cultured with (+) or without (−) Acr1 (9 µg/mL) and estimated for the secretion of IL-12 by enzyme-linked immunosorbent assay. Data expressed as pg/mL are representative of 3 independent experiments. Data points show mean ± SD. Data were analyzed with 2-tailed unpaired t test. Acr1(−) and Acr1(+), signify 0 and 9 µg/mL of Acr1. *P < .05, **P < .005, ***P < .0005. Figure 2 . Acr1 impairs antigen uptake by dendritic cells (DCs) and their ability to activate T cells. Acr1DCs were generated in the presence of indicated concentrations of Acr1. Antigen uptake was monitored by (A) flow cytometry; (B and C) confocal microscopy (dextran-fluorescein isothiocyanate [FITC] ); (D) spectroscopy (horseradish peroxidase). Data represent mean ± SEM (ng/mL) and are of 2 independent experiments. Statistical analysis was done with Student Newman-Keuls multiple comparison test. ***P < .001. E-G, DCs generated in the presence (9 µg/mL) or absence (0 µg/mL) of Acr1 were cultured with allogeneic T cells. E, Proliferation of T cells is represented as counts per minute (cpm). Supernatants were estimated for (F ) interleukin 5 (IL-5) and (G) interferon gamma (IFN-γ). The data represent mean ± SEM ( pg/mL) and are representative of 3 independent experiments. Data were analyzed with 2-tailed unpaired t test. *P < .05, **P < .005.
Interestingly, Acr1 induced a significant (P < .0005) decrease in the yield of IL-12 ( Figure 1G) , and therefore may obstruct in the generation of Th1 cells. The overall data ( Figure 1A-G (Figure 1 ). Hence, we next monitored antigen uptake capacity of such DCs and their ability to help T cells. Our flow cytometry, confocal microscopy, and spectrophotometry data exhibited a significant decrease in the antigen uptake by Acr1DCs (Figure 2A-D) . Furthermore, Acr1DCs also significantly (P < .005) suppressed the proliferation of T cells ( Figure 2E ), secretion of IL-5, and IFN-γ ( Figure 2F and 2G). Optimal activation of T cells was noticed in control cultures where DCs were generated in the absence of Acr1. In essence, Acr1 impedes the ability of DCs to help T cells.
Increased Survival of M. tuberculosis in Acr1DCs
DCs can engulf and kill M. tuberculosis. Because Acr1DCs exhibited suppressive phenotype and reduced ability to help T cells, we next assessed the killing capacity of Acr1DCs. As compared to the control DCs (-Acr1), Acr1DCs showed reduced ability to kill M. tuberculosis. This was evidenced by considerable increase in the M. tuberculosis colony-forming units in Acr1DCs (Figure 3 ).
Acr1 Induces Tolerogenic Phenotype in DCs
Immune tolerance is associated with chronic diseases such as tuberculosis and cancer. Besides DC's crucial contribution in the activation of the immune system, their role is also surfaced in the induction of tolerance [23, 29] . Acr1DCs exhibited increased expression of PD-L1 and Tim-3 ( Figure 1C and 1E) . PD-L1 and Tim-3 are involved in the generation of tolerance in DCs [30] [31] [32] . The influence of tryptophan catabolizing enzyme indoleamine 2, 3-dioxygenase (IDO), IL-10, and transforming growth factor beta (TGF-β) have also been deciphered in DC's tolerance. Amazingly, we found a significant increase (P < .01) in the level of IDO in the Acr1DCs ( Figure 4A and 4B). The change was noticed in a dose-dependent manner. Enhancement in the yield of TGF-β and IL-10 (P < .05) was also observed ( Figure 4C and 4D ). IDO and PD-L1 are associated with the induction of Tregs. Remarkably, Acr1DCs also expanded the pool of Foxp3-expressing Tregs ( Figure 4E ). In conclusion, Acr1DCs expressed enhanced levels of IL-10, TGF-β, and IDO, and promoted Treg generation.
Acr1 Modulates the Expression of SOCS Molecules
It has been demonstrated that SOCS-1, 2, and 3 are involved in the activation and differentiation of DCs [33] [34] [35] . Interestingly, we found a significant increase of SOCS-3 (P < .0005), at both the messenger RNA and protein levels in Acr1DCs ( Figure 5A and 5B). However, reduction (P < .05) was observed in SOCS-1 and SOCS-2 ( Figure 5C and 5D). These results indicate that Acr1 differentially regulate the expression of SOCS molecules, ultimately modulating the JAK/STAT pathway and weakening the function of Acr1DCs.
Acr1 Activates STAT-3 but Inhibits STAT-6 SOCS molecules negatively regulate the JAK/STAT pathway [35] . Interestingly, we observed decreased expression and phosphorylation of STAT-6 in Acr1DCs ( Figure 6A ). In contrast, a substantial increase was observed in the phosphorylation of STAT-3 ( Figure 6B ). It has been established that STAT-3 is involved in the induction of tolerogenic phenotype of DCs by upregulating PD-L1 [30, 36] . This correlated with increased PD-L1 by Acr1 on Acr1DCs ( Figure 1C) . No change was seen in STAT-1 (Supplementary Figure 3) . These results support substantially that Acr1 retards the activation of DCs.
Acr1 Inhibits NF-κB Nuclear Translocation
The DC maturation and cytokines secretion are NF-κB dependent [37] . We observed that Acr1DCs show suppression in Figure 3 . Mycobacterium tuberculosis (M. tuberculosis) shows increased survival in Acr1 dendritic cells (DCs). DCs cultured in the absence (−) and presence (+) of 0 µg/mL and 9 µg/mL of Acr1, respectively, were infected with M. tuberculosis for 4 hours, followed by incubation for 24 hours. Later, the DCs were lysed and plating was done and M. tuberculosis colonies were enumerated on day 21. Bar graph represents mean ± SEM of colony-forming units (CFU)/mL and is from quadruplet analysis. Data were analyzed with 1-tailed unpaired t test. ***P < .0005. Figure 1G ). Hence, we hypothesize that Acr1DCs may be exhibiting reduction in the nuclear translocation of NF-κB ( Figure 7 ). This implies a unique property of Acr1 in attenuating NF-κB activity in Acr1DCs, thereby establishing the role of this latency-associated antigen in suppressing the function of Acr1DCs. 
IL-12 secretion (
DISCUSSION
In tuberculosis-endemic areas, >90% of healthy persons are latently infected with M. tuberculosis, yet do not manifest disease symptoms [38] . Nonetheless, there is always an associated risk of activation of disease in 10%-15% of these individuals. M. tuberculosis successfully evades the immune system and can establish its persistence in the host by rapidly altering its gene expression and releasing several factors [39, 40] . Hence, latently infected people act as a reservoir of the M. tuberculosis and can always be a potential threat for spreading the disease. Therefore, it is quite crucial to understand the role of factors released during latency by M. tuberculosis and their role in impairing the immunity of the host. Macrophages and DCs are responsible for restricting M. tuberculosis infection and establishment of immunity. Even though macrophages can efficiently phagocytose M. tuberculosis, the bacterium can methodically antagonize the activity of these cells and thrives in their inimical milieu. DCs are decisive in the initiation of immune responses due to their distinctive competence of activating naive T cells. In the case of M. tuberculosis infection, DCs not only fail to eliminate the mycobacterium but surprisingly, also help in spreading the infection [5, 41] . Understanding the mechanism involved in the modulation of the activity of DCs by M. tuberculosis antigens, particularly those induced during latency, can provide insight in understanding the immune evasion by the bacterium [42] .
Acr1 is predominantly expressed during the dormant stage of M. tuberculosis. Whether this antigen is employed by M. tuberculosis in exploiting the function of DCs remains unexplored. Therefore, we deciphered the role of Acr1 in influencing the maturation and function of DCs. The following major findings emerged from the current study: Acr1 suppressed the activity of Acr1DCs as evidenced by (i) decrease in the percentage of CD11c/CD86 + cells; (ii) downregulation of MHC-II and costimulatory molecules CD80, CD86, CD40 and + DCs cultured in the absence and in presence, respectively, of Acr1 (9 µg/mL) antigen. Bar graph implies relative expression of (B) SOCS-3, (C) SOCS-1 and (D) SOCS-2. The comparison was done with respective to control DCs (-Acr1). mRNA level was normalized to β-actin mRNA. Data are expressed as mean ± SEM and are representative of 2 independent experiments. Data were analyzed with 2-tailed unpaired t test. *P < .05, ***P < .0005. Abbreviation: n.s., nonsignificant. induction of Tregs. To best of our knowledge, this is a first report precisely demonstrating the role of Acr1 in restraining the maturation, differentiation, and functionality of DCs. The interaction of T cells with DCs plays a fundamental role in eradicating intracellular pathogens. The optimum activation of naive T cells is accomplished by occupancy of the T-cell receptor by the peptide-MHC complex presented on the surface of DCs and delivery of costimulatory signals [43] . The extent of expression of costimulatory molecules is critical in shaping the nature and magnitude of the immune response. Thus, an encounter of peptide-MHC on the surface of DCs can result in 2 discrete events in T cells: (i) proliferation and differentiation into effector cells; and (ii) anergy, a state of unresponsiveness. The expression of costimulatory molecules may impart an imperative role during the course of acute and latent disease and its remission or relapse. Hence, modulation of these molecules by pathogens can help them to evade immune system and establish their existence in the host. We have elaborated the impact of latency-associated antigen Acr1 employed by M. tuberculosis to break the code of conduct of costimulatory molecules (CD80, CD86, and CD40) to enhance its survival and establishing infection. CD80, CD86, and CD40 are considered to be key molecules responsible for the activation of T cells. M. tuberculosis is known to impair the maturation of DCs hi and their ability to activate T cells [44] . There are several reports signifying the role of mycobacteria in downregulating the expression of CD80, CD86, and CD40 on APCs, but we have for the first time dissected the role of Acr1, responsible for this phenomenon. Further, Acr1DCs also exhibited an augmented level of PD-L1 and Tim-3. [30, 46] . In essence, these findings suggest that M. tuberculosis employs its Acr1 to make DCs incapable of optimally activating T cells and crafting ambient conditions for its survival. We further substantiated the role of Acr1 in suppressing the function of Acr1DCs by dissecting its mechanism. Recently, it has been reported that SOCS protein can be upregulated in monocytes, macrophages, and DCs by M. tuberculosis [33, 47] . SOCS molecules act as a negative regulator of the JAK/STAT pathway [35] . There was a considerable reduction in the expression of SOCS-2 whereas an increase in phosphorylation of STAT-3 was observed in Acr1DCs. Silencing of SOCS-2 inhibits activation of DCs by stimulating hyperphosphorylation of STAT-3 [48] . Continuous activation of STAT-3 inhibits the nuclear translocation of NF-κB [30, 35] . It has been reported that a decrease in the phosphorylation of STAT-6 reduces the responsiveness of IL-4 and thus inhibits the activation of DCs [49] . We also observed a significant increase in the expression of SOCS-3, which can be explained by augmented IL-10 but low IL-12 secretion ( Figure 4D ). DCs overexpressing SOCS-3 produce a low quantity of IL-12 but a high amount of IL-10 with tolerogenic phenotype [50] . All the pathways shown to be perturbed due to Acr1 treatment of DCs also exist in other phagocytic cells and APCs such as macrophages [23, 39] ; therefore, M. tuberculosis can also deteriorate macrophage activity. Thereby, the bug escapes intracellular destruction, multiplies, and disrupts the function of APCs.
Finally, this study suggests that Acr1 of M. tuberculosis successfully impairs the function of DCs. Consequently, M. tuberculosis may establish its persistence in the host. Hence, neutralizing the activity of Acr1 by either vaccine or drug can be quite crucial to circumvent the impairment of the function of the host DCs. A vaccine should evoke immunity against Acr1, whereas designing a kinase inhibitor offers an attractive drug target [16] .
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